🇺🇸 FDA
Patent

US 11160872

Pyrrolobenzodiazepine-antibody conjugates

granted A61KA61K31/5517A61K45/06

Quick answer

US patent 11160872 (Pyrrolobenzodiazepine-antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ADC THERAPEUTICS SA
Grant date
Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/5517, A61K45/06, A61K47/68035, A61K47/6849